What is the recommended starting dose and titration plan for OxyContin (extended‑release oxycodone) in an opioid‑naïve adult with moderate to severe chronic pain?

OxyContin Dosing for Opioid-Naïve Adults

For opioid-naïve adults with moderate to severe chronic pain, start OxyContin at 10 mg every 12 hours, with consideration of using 5 mg (half tablet) for frail or elderly patients. 1

Starting Dose

The FDA-approved OxyContin label provides explicit guidance for opioid-naïve patients:

• Standard starting dose: 10 mg every 12 hours 1
• Lower starting dose: 5 mg (half tablet) every 12 hours for frail or elderly patients 1
• Critical caveat: If calculated total daily dose is less than 20 mg, there is no safe strength for conversion and OxyContin should not be initiated 1

This contrasts with immediate-release morphine, which remains the gold standard first-line opioid. The most recent NCCN guidelines (2025) recommend starting with 5-15 mg of oral short-acting morphine sulfate for opioid-naïve patients 2. However, when extended-release formulations are specifically indicated, OxyContin provides a reasonable alternative.

Important Prescribing Principle

Extended-release formulations like OxyContin should NOT be used as first-line therapy in opioid-naïve patients. The 2022 CDC guidelines explicitly state that clinicians should not initiate opioid treatment for chronic pain with ER/LA opioids 3. The 2025 NCCN guidelines similarly emphasize that extended-release opioids should be "reserved for severe, continuous pain" and considered only after patients have received immediate-release opioids (e.g., 60 mg daily of oral morphine or 30 mg daily of oral oxycodone) for at least 1 week 2.

Titration Protocol

Once initiated, follow this structured approach:

Timing of dose adjustments:

• Steady-state plasma concentrations are reached in approximately 1 day 1
• Adjust dosage every 1-2 days as needed 1

Magnitude of dose increases:

• Adults: Increase by 25-50% of current total daily dose when clinically indicated 1
• Pediatric patients (11+ years): Increase by 25% of current total daily dose 1

Breakthrough pain management:

• Provide immediate-release opioid rescue doses equivalent to 10-20% of the 24-hour total opioid dose 4
• If more than 4 breakthrough doses per day are needed, increase the baseline extended-release dose 4

Monitoring Schedule

Early phase (first 1-4 weeks):

• Evaluate benefits and harms within 1-4 weeks of starting therapy 5
• Consider shorter intervals (within 3 days) when total daily dose reaches 50 MME or greater 5

Maintenance phase:

• Reassess every 3 months or more frequently 5
• If benefits do not outweigh harms, optimize other therapies and consider tapering 5

Critical Safety Considerations

Dose thresholds requiring heightened caution:

• At 50 MME/day: Implement additional precautions including increased follow-up frequency and consider offering naloxone 5
• At 90 MME/day: Avoid reaching this threshold or carefully justify the decision based on individualized risk-benefit assessment 5

Formulation-specific warnings:

• Tablets must be swallowed whole—never broken, chewed, or crushed 6
• No food interference with absorption 6
• No dose reduction needed for moderate hepatic or renal failure, but use caution due to potential metabolite accumulation 2, 6

Common Pitfalls to Avoid

1. Starting with extended-release in opioid-naïve patients: This violates current guidelines and increases overdose risk. Always start with immediate-release formulations unless the patient is already opioid-tolerant 2, 3.

2. Inadequate breakthrough pain coverage: Failing to provide immediate-release rescue medication leads to poor pain control and patient dissatisfaction 4.

3. Rapid dose escalation: Increasing doses more frequently than every 1-2 days doesn't allow for steady-state assessment and increases adverse event risk 1.

4. Ignoring the 20 mg minimum: If conversion calculations yield less than 20 mg total daily dose, OxyContin cannot be safely initiated 1.

5. Using OxyContin for intermittent pain: Extended-release formulations are only appropriate for continuous, around-the-clock pain 3.

Alternative First-Line Approach

Given the guideline recommendations, the preferred approach for opioid-naïve patients is:

1. Start with immediate-release morphine 5-15 mg every 4 hours 2
2. Titrate over several days to achieve pain control
3. Once stable on immediate-release opioids for at least 1 week at doses equivalent to 60 mg oral morphine daily, consider conversion to OxyContin 20 mg every 12 hours 2

This stepwise approach aligns with both the 2025 NCCN cancer pain guidelines 2 and the 2022 CDC opioid prescribing guidelines 3, prioritizing patient safety while achieving effective analgesia.